Celldex Therapeutics Inc.

NASDAQ:CLDX   4:00:00 PM EDT
37.09
+2.83 (+8.26%)
6:25:31 PM EDT: $37.14 +0.05 (+0.14%)
Earnings Announcements

Celldex Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 21:17 GMT
Celldex Therapeutics Inc. (CLDX) - Celldex Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Q3 Revenue $400,000.
Q3 Loss per Share $0.57.
Total Revenue Was $0.4 Million in Q3 of 2022 Compared to $0.2 Million.
Q3 Earnings per Share View $-0.58, Revenue View $360000.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.26 Million
Adjusted EPS is expected to be -$0.59

Next Quarter Revenue Guidance is expected to be $0.65 Million
Next Quarter EPS Guidance is expected to be -$1.20

More details on our Analysts Page.